Xth ICORD Conference, Mexico City, 15



Xth ICORD Conference, Mexico City, 15
Xth ICORD Conference, Mexico City, 15-16 Oct 2015
Preliminary Programme (May version)
A decade of discoveries and current challenges in the world of RD and OD
DAY 1- Thursday 15 October
Venue: ISSSTE Buenavista, Mexico City
Opening (30 min)
Session I: Global Strategies for Rare Diseases
- John Forman (ICORD President, New Zealand) - ICORD’s vision and the Yukiwariso Declaration.
- Nicola Magrini (WHO, Switzerland)
- Presentations from invited speakers
Coffee Break
Session II: Update on The Latin American Rare Diseases Status
Moderators: Virginia Llera (GEISER, Argentina) and David Peña (FEMEXER, Mexico)
-Mario Alanis (Federal Commission for Protection against Health Risks, COFEPRIS, Mexico),
Regulatory facts and needs
-Ignacio Burgos (Spain), Progress on regional laws
-Emilio Roldan (SLADIMER, Argentina), Science and Industry possibilities in Latin America
-Virginia Llera (GEISER, Argentina), About the Rare Diseases Latin American Day
11.45 -12:30
Session III: The ethics of resource allocation for Rare Diseases
Keynote lecture
Mariana Kruger (Stellenbosch University, South Africa)
Lunch Break
Session IV: Inborn errors of metabolism as an example of RD
Moderator: Stephen Groft (NIH, USA)
Presentations and panel discussion
- Olaf Bodamer (Harvard University, USA), Medical perspective. A short introduction to metabolic
- Luis Barrera (Javeriana University, Colombia), Research perspective. What research is
- Fernando Royo (Genzyme, Spain), Industry perspective
- Patient perspective
- Authority perspective
- Panel discussion with all presenters. Current challenges, differences around the globe.
Part of the Global Rare Diseases Week, Latin America 2015
Coffee Break
Session V: Prevention
Invited speakers and Free abstracts
- José F Cordero (University of Puerto Rico, Puerto Rico) – Prevention and birth defects
- Domenica Taruscio (Istituto Superiore di Sanità, Italy) - European Recommendations on policies
for the primary prevention of congenital anomalies
- Slot reserved for the best abstract selected by the scientific committee
Session VI: Networking session/Discussion groups session - Moving Research Discoveries to
Diagnostic and Treatment Interventions: Opportunities for Collaborative Working Partnerships
Conference participants are welcome to join the discussion group of interest.
Discussion groups:
1. Communication: Crowdsourcing and Social Media Role
 Education of Policy Makers, Regulatory Agencies, Grant Making Organizations,
Identify Funding Sources, and Recruiting Patients for Clinical Studies
Research Infrastructures
 Natural History Studies, Patient Registries, and Biospecimen Collections
Changes in Regulatory Environment
 Patient, Family, and Physician Risk Acceptance
and Risk Tolerance
 Expedited Review, Breakthrough Therapies, Accelerated Approval, Priority and Fast
Track Review
Access to Diagnostics and Treatment Interventions
 Genetic Testing, and Whole Genome, Exome, and Next Generation Sequencing
 Drug Re-Purposing of Existing Products
Establishing Research Partnerships
 Industry, Private Foundations, Academic Researchers, Government Agencies, and
Translational Research Programs, Research Conferences
The Right to Health
International Law, National Constitutions, Human Rights Legislation, Moral
Philosophy, and Health System Policy – how these combine and influence the
delivery of health care, especially to disadvantaged and vulnerable populations
ICORD General Assembly (ICORD members only)
Part of the Global Rare Diseases Week, Latin America 2015
DAY 2- Friday 16 October
Venue: ISSSTE Buenavista, Mexico City
Session VII: Patients’ voices: International cooperation within patient groups. Why, Who
and How?
Moderator: Virginia Llera (GEISER, Argentina)
- Paloma Tejada (EURORDIS, Rare Disease International, France)
- Natasha Bonhomme (Genetic Alliance, USA)
- David Peña (FEMEXER, Mexico)
Coffee Break
Session VIII: Building the Undiagnosed Diseases Program to a global network
Keynote lecture
Session IX: Poster Session
Lunch Break
Session X: Spreading the word - Incentives for OD development are needed around the
- Presentations from invited speakers
Session XI: Development and accessibility to international registries and biobanks
Moderator: Domenica Taruscio (ISS, Italy)
- Yaffa Rubinstein (Global Rare Diseases Patient Registry Data Repository, NIH, USA) – Title
to be decided
- Manuel Posada (Instituto de Salud Carlos III, Spain), Medical ontologies and registering
activities. What are their added values?
- Slot reserved for the best abstract selected by the scientific committee
Coffee Break
Session XII: Examples of successful RD collaborations. Progresses in the RD field the last
10 years and futuristic outlooks.
- Rashmi Gopal-Srivastava (ORDR, NIH, USA) - The Rare Diseases Clinical Research Network,
- Antoni Matilla Dueñas (Health Sciences Institute Germans Trias i Pujol, Spain) -The
RIBERMOV Latin-American collaboration
- Slots reserved for the best abstract selected by the scientific committee
Conclusions and Conference Closing
Press Conference: David Peña, Virginia Llera, John Forman, Manuel Posada
Part of the Global Rare Diseases Week, Latin America 2015

Similar documents

China Rare Earth Market - Industry Analysis and Forecast by Radiant Insights, Inc

China Rare Earth Market - Industry Analysis and Forecast by Radiant Insights, Inc The rare earth elements are naturally occurring non-toxic elements that have distinctive properties. These properties have made these elements essential to several rising technologies that contribute to energy efficiency, health, and environmental solutions. There are numerous uses of these elements such as; Neodymium is utilized in radiation filtering & magnets, Yttrium is utilized in superconductors, microwave filters, & laser technology, Europium is utilized in laser technology, nuclear reactors, & televisions. China is the leading rare earth elements supplier across the globe. In 2009, the global rare earth elements production was valued at 126,230 metric tons, with China producing about 95% of it. China became the dominant market for rare earth elements when it started producing & supplying these elements at prices that no other western manufacturer could compete with. It is anticipated to be the dominant market for rare earth elements over the next few years, occupying over two-thirds of the overall demands in 2019. Click For Report Details @ http://www.radiantinsights.com/research/rare-earth-markets-in-china

More information